SORIS Success Story

In July 1999 British Technology Group asked SORIS for a GMP supplier of polidocanol.  [It further asked for “no publicity”].

The pharmaceutical for which polidocanol is a key intermediate is now about to launch (after a £200m investment) in the treatment of varicose veins.  A Yorkshire chemical company has been part of the development programme and will supply the intermediate.